A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Inventiva’s lead product candidate, lanifibranor, is currently in a pivotal Phase III clinical trial, NATiV3, for the treatment of adult patients with MASH, a common and progressive chronic liver ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the ...

John Schwope, President and CEO for Simplified Clinical states, “As a contributing member of Microsoft’s AI Cloud Partner program, we share Microsoft’s vision for the future of clinical research data ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Antibiotic overuse is a key driver in the rise of antimicrobial resistance (AMR), a major global health crisis.

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced ...

Despite the economic uncertainties, healthcare analytics companies have demonstrated strong resilience throughout 2024. The global healthcare analytics industry market size is estimated to grow from ...